FLOGEN Logo
In Honor of Nobel Laureate Dr. Aaron Ciechanover

SIPS 2025 logo
SIPS 2025 takes place from November 17-20, 2025 at the Dusit Thani Mactan Resort in Cebu, Philippines

Honoree Banner

More than 400 abstracts submitted from over 50 countries
Abstracts Still Accepted for a Limited Time



Featuring many Nobel Laureates and other Distinguished Guests

List of abstracts

As of 25/11/2025: (Alphabetical Order)

Tanner International Symposium (2nd Intl. Symp. on Pharmaceutical Sciences and Industrial Applications for Sustainable Development)

To be Updated with new approved abstracts

COMPUTATIONAL PREDICTION OF AN IMPORTANT PROTEIN’S STRUCTURE
Ang-Yang Yu1
1Heilongjiang Vocational College of Biology Science and Technology, Heilongjiang, China
sips25_73_6

ß-lactam enzyme antibiotic is one of the most effective chemotherapy medicine in treating bacteria infection. Inhibitor of metal 2-lactam enzyme is an important topic in clinical medical science during the historic development of antibiotics in the past sixty years since the discovery of penicillin. The most common resistance mechanism is to hydrolysis the enzyme of these antibiotics, known as ß-lactam enzyme. Metal ß-lactam enzyme has a very rare wide substrate surface, which can prohibit the movement of bicyclic ß-lactam antibiotics. The research focus in medical science is concentrated on ß-lactam enzyme’s structure and inhibitor design.

In my own work, an important protein system, named as metal ß-lactam enzyme of arc-shaped stem fungus, is investigated theoretically. The three-dimensional structure of metal ß-lactam enzyme of arc-shaped stem fungus is obtained by means of homology modeling and molecular dynamics simulation. Additionally, active sites have been predicted according to the catalysis mechanism of metal ß-lactam enzyme of arc-shaped stem fungus. Finally, our computed results are compared with previous reports of relevance. The differences have been analyzed and discussed.


FORMULATION DEVELOPMENT BY SPRAY FREEZE-DRYING TECHNOLOGY IN SHIONOGI
Go Kimura1; Shuichi Otake1; Akira Mashimo1
1Shionogi & Co., Ltd., Amagasaki, Japan
sips25_73_30

The spray freeze-drying system is a type of freeze-drying method. This technology is a hybrid pharmaceutical manufacturing technology that combines the spray drying and freeze-drying which are existing manufacturing technologies [1].

Its introduction into the pharmaceutical industry has begun to be considered as an alternative manufacturing method to conventional freeze-drying technology [2].

Spray freeze-drying system can be applied to various pharmaceuticals regardless of modality. This technology has the potential to be a useful solution to formulation issues that were difficult to solve with conventional freeze-drying technology. Thus, it is expected that this technology, which can be used from the perspective of both formulation design and commercial manufacturing, will become more widespread in the future.

In this presentation, the case studies in Shionogi using sucrose and model liposomes with a view to applying spray freeze-drying to pharmaceutical development will be addressed [3]. The former case is a study aimed at applying spray freeze-drying to low molecular weight compounds, and the latter case is a study aimed at applying spray freeze-drying to soft materials.

References:
[1] B.Luy, PHRMA TECH JAPAN, Vol.33, No.14, 15-21 (2017)
[2] H. Leuenberger, M. Plitzko, M. Puchkov, Drying Technology, 24 (6), 711-719 (2006)
[3] S. Otake, A. Mashimo, G. Kimura, PHRMA TECH JAPAN, Vol.41, No.1, 27-31 (2025)



FROM “PUBLISH OR PERISH” TO “PUBLISH AND PERISH” – YOUNG SCIENTISTS BEING STRUCK BETWEEN SCIENCE AND FUNDING
Eva Roblegg1; Martin Bultmann2
1Institute of Pharmaceutical Sciences, Pharmaceutical Technology and Biopharmacy, Graz, Austria; 2University of Heidelberg, Heidelberg, Germany
sips25_73_307_FS

Education is not only one of the 17 United Nations Sustainable Development Goals (SDG) [1] but it also plays a detrimental role in achieving sustainability [240]. Education implies active and passive access to knowledge, which comprises unbiased access to scientific literature as a major component. Up to the 1980s this meant textbooks and journal articles, that had to be bought by the recipient or borrowed from a local or remote library free of charge or for a comparably small fee.

An additional source of information came in the 1990s when the internet entered offices, and private households. Initially, all the information was publically available free of charge, but eventually commercialization set in.

On the other end of the spectrum are the scientists, whose research culminates in the generation of knowledge, evident by publication. Simplified, a researcher builds his/her scientific reputation on the number of publications authored. Publications became -and still are- a kind of virtual currency in academia – “Publish or perish”.

Comparing the supply chain of knowledge with that of typical other goods, there always used to be a slight mismatch between the flow of goods and services and the flow of money. There is a strong similarity between common goods and books, where supplier and author are compensated (e.g. 10% of sales price for authors) and a quality check is incorporated; either at supplier, wholeseller or retail shop, and this quality assurance (QA) function might be internal or outsourced. However, usually scientific print journals did not pay the authors for content nor were peer reviewers paid. The customer or reader is charged for the goods or literature received. However, libraries served as a cost effective way to make knowledge cost effectively available.

The situation intiensified and the mismatch became even more evident since the introduction of open access or public access schemes: To allow open access for the user, the publisher requires the inversion of monetary flow through reimbursment by the author. This means the content provider now also provides the financial funding (typically a mid four-figure USD amount per publication)!

Especially early career scientists are hurt the most by open access publishing schemes: On the one hand they need to build their reputation by publishing their findings, but it is not only the publication itself that counts; it is also the number of citations that one receives. The lower the threshold for readers the more citaions. Any kind of restricted access poses a hurdle for the readers and the likelihood for being cited diminishes.

On the other hand, without reputation it is hard to get funding for research work and if the scarce funds have to go to the publisher, then there’s hardly any leftover for research (Publish and perish)  and vice versa. A vicious circle right from the start that is hard to overcome; especially if the job of the scientist also comprises teaching (fulfilling educational service aka spreading knowledge to the students) by lecturing, supervising and conducting lab courses).

This article describes approaches to escape this conundrum. 

References:
[1] United Nations Department of Economic and Social Affairs Sustainability Development Goals [Internet]. [cited 22.Apr.2024]. Available from http://sdgs.un.org/goals
[2] Bultmann, J M, SUSTAINABILITY IN BIG PHARMA – CAN SUPERCOMPUTING DO THE TRICK? [proceedings] SUSTAINABLE INDUSTRIAL PROCESSING SUMMIT AND EXHIBITION, Iraklion, Crete, 2024



HADRONIC MEDICINE: INITIATION OF A QUANTITATIVE REPRESENTATION OF LIFE VIA THE HYPERSTRUCTURAL ENTANGLEMENT OF LIVING ENTITIES
Ruggero Maria Santilli1; Federico Inglese2; Emanuele Velardo1; Thomas Vougiouklis3
1The Institute for Basic Research, Palm Harbor, United States; 2Citozeatec, Peschiera Borromeo, Italy; 3Democritus University of Thrace, Xanthi, Greece
sips25_73_362

We first review the initiation by two of us (R. M. S. and T. V.) [1] of the mathematical representation of life, intended as the difference between organic and inorganic molecules, via the Lie-admissible hyperstructural branch of hadronic mechanics representing the size of biological molecules, their contact thus non-Hamiltonian interactions and the irreversibility over time. We then review and expand the studies done in the subsequent paper [2] showing that: 1) The time irreversible hadronic representation of life can be obtained via the addition of the symmetric Jordan brackets to reversible quantum mechanical Lie brackets; 2) The Lie and Jordan admissible axiomatic formulation of hadronic medicine with non-linear, non-local an non Hamiltonian entanglements of molecular constituents operating without the use of a known form of energy; 3) The smooth connection between hadronic uncertainties at small distances and full Einsteinian determinism at classical distances; 4) The quantitative representation by hadronic medicine of some actions by biological entities beyond our sensory perception; 5) The expected diagnostic and curative values of hadronic medicine.

References:
[1] R. M. Santilli and T. Vougiouklis, A New Conception of Living Organisms and its Representation via Lie-Admissible Hv-Hyperstructures, Algebras, Groups and Geometries 37, 741-764 (2020), www.santilli-foundation.org/docs/Santilli-Vougiouklis-2020-epr.pd
[2] F. Inglese, E. Velardo, R. M. Santilli and Th. Vougiouklis: Lie-admissible irreversible biological entanglements and their apparent initiation of hadronic medicine Ratio Mathematica 54, 1-32 (2025), http://www.santilli-foundation.org/docs/hadronic-medicine.pdf



INFLUENCE OF A THERAPEUTIC MONOCLONAL ANTIBODY FORMULATION BEFORE AND AFTER IRRADIATION ON THE SURFACE TENSIOMETRY PROPERTIES OF BLOOD DROPLETS BY THE CONTACT ANGLE METHOD
Davide Rossi1, 2; Giorgia Miolo2
1Development Cooperation Association BAZH.I, Maserada Sul Piave, Italy; 2University of Padova, Padova, Italy
sips25_73_249

During storage, transport, dilution and intravenous (i.v.) administration, mAbs are exposed to different stressors, including artificial and indoor ambient light, which can compromise their efficacy and safety. Light can induce concentration-dependent aggregation, leading to a measurable reduction in the drug's ability to bind its target The surface tensiometry properties of monoclonal antibodies (mAbs) were recently characterized using the Solid-like Methodology (SLM) [1] applying the Contact Angle Method (CA) [2]. The SLM consists in the deposition of a hydrophobic, lipophobic and self-repellent “liquid film”, called polyperfluorometylisopropyl ether (PFPE) [3] used as “solid substrate” for the characterization of liquid systems droplets [4]. This SLM consents the determination of Surface Tension (ST; mN/m), Dispersion Component (DC; mN/m) and Polar Component (PC; mN/m) of liquids without the influence of friction forces and surface roughness and was largely applied in the field of pharmaceutical technology [5]. The Well methodology (WM) [5] derives from the concept of Solid-like Methodology (SLM); unlike the SLM, the WM consists in the deposition of an amount of PFPE (PFPEw) leaved in a ceramic concave support (well). When a drop of liquid comes in contact with the surface of the PFPEw, a characteristic meniscus is formed caused by the hydrophilic/lipophilic ratio of the liquid (corresponds to its surface chemistry) in relation to the hydrophobic, lipophobic and self-repellent properties of PFPEw at the interface. The WM was here used to determine the surface tensiometry properties of human blood (Hb, G.M. droplets) and its variations after the addition with Nivolumab/Opdivo® (Opdivo samples/Hb complex system) as such and diluted in glucose and NaCl before and after light treatment with 720.0 and 10.460 KJ/m2. The surface tensiometry parameter used here is the Vertical Drop Speed (VDS: dSA/dt) which measures the rate at which a drop of mAb sample spreads vertically at the interface with PFPEw. As first result, the VDS Opdivoâ formulation values (6.3E-05±4.8E-05) tend to decrease strongly after treatment with 720.0 KJ/m2 (2.9E-05±7.9E-06) and more at 10460 KJ/m2 (2.2E-05±8E-06) due to the degradation of Opdivoâ under the light stressor. Differently, the Hb/Opdivoâ complex system VDS values (9.7E-05±5.3E-05) are quite the same after 720.0 KJ/m2 (1.0E-04±4.0E-05) and slightly decrease only after 10460 KJ/m2 (7.3E-05±3.6E-05). This result appears to be correlated with the presence of blood components in the system, which maintains  high VDS values due to the strong affinity between mAb and blood components. The presence of 5% glucose (Opdivoâ-glu) as cosolvent reveals the equilibrium between Opdivoâ-glu (3.4E-05±9.1E-06) and blood (9.6E-05±4.6E-05) in the Hb/Opdivoâ-glu complex system (7.5E-05±3.1E-05). The treatment of Opdivoâ-glu with 720.0 KJ/m2 and 10460 KJ/m2 causes, respectively, slight (Opdivoâ-glu; 2.8E-05±5.2E-06, Hb/Opdivoâ-glu; 8.7E-05±3.8E-05, blood; 9.6E-05±4.6E-05) and strong (Opdivoâ-glu; 5.5E-05±1.6E-05, Hb/Opdivoâ-glu; 1.7E-04±8.1E-05, blood; 9.6E-05±4.6E-05) equilibrium decreases due to the great increase of VDS of Hb/Opdivoâ-glu (10460 KJ/m2). This seems due to the increase of aggregates in Opdivoâ-glu after light treatments amplified by the presence of blood components. The presence of 0.9% NaCl demonstrates a disequilibrium between Opdivoâ-NaCl (6.2E-05±2.1E-05) and blood (9.6E-05±4.6E-05) due to lower VDS value of Hb/Opdivoâ-NaCl.(1.4E-05±1.0E-06). That equilibrium is reached after treatment of Opdivoâ-NaCl with 720.0 KJ/m2 (Opdivoâ-NaCl; 4.8E-05±1.4E-05, Hb/Opdivoâ-glu; 7.1E-05±2.7E-05, blood; 9.6E-05±4.6E-05) and marked decreased after treatment with 10460 KJ/m2 (Opdivoâ-NaCl; 4.7E-05±1.2E-05, Hb/Opdivoâ-glu; 1.2E-04±5E-05, blood; 9.6E-05±4.6E-05). However, the increase of Hb/Hb/Opdivoâ-glu as aggregates in NaCl irradiated Opdivo are formed in less amount. With this work we demonstrate the different behaviour of dark and irradiated samples and the difference between undiluted and diluted (NaCl and glucose) Opdivo samples when come in contact with blood. Therefore, we try to mimic the i.v. administration of this drug: when aggregation takes place, mostly under the light exposure and even more in glucose solution, the WM can promptly detect the physical differences among the samples. Our findings indicate that mAbs should be protected from light, especially during prolonged i.v. administration periods, to avoid aggregate formation and potentially reduction of their therapeutic activity.

References:
[1] Miolo G, De Diana E, Polverino De Laureto P, Realdon N, Rossi S, Rossi D. J Pharm Sci, 114 (7):1-12, 2025.
[2] Etzler FM. Mittal (eds) Advances in Contact Angle Wettability&Adhesion, 13: 229-329. Scrivener Publishing LLC, 2018.
[3] Rossi D. Balneo and PRM Research Journal, 14(4):1-17, 2023.
[4] Rossi D, Rossi S, Realdon N. Mittal (ed) Advances and Contact Angles Wettability&Adhesion, 4:145-178. Scrivener Publishing, Beverly, MA, 2019.
[5] Rossi D, Vettorato E, Franceschinis E. Grotto A. Favaro A. Realdon N. Progress in Adhesion & Adhesives IN PRESS 2025.



INTRINSICALLY DISORDERED PROTEINS AS DRUG TARGETS
Assaf Friedler1
1The Hebrew University of Jerusalem, Jerusalem, Israel
sips25_73_323

Protein-Protein Interactions (PPI) mediate numerous processes in cells in health and disease. However, it is extremely challenging to make them drug targets. This is especially true for intrinsically disordered proteins (IDPs). The research in our lab focuses on using peptides for the quantitative biophysical and structural analysis of PPI. Based on this, we develop lead peptides that modulate PPI for therapeutic purposes. Our latest research directions include:

  1. Control of condensation and aggregation of proteins by multiphosphorylation: Specific phosphorylation patterns dictate the activity and interactions of many proteins. We developed new methods for rapid and efficient of peptide libraries with distinct multi-phosphorylation patterns. This enables systematic studying at the level of isolated protein domains. We used these tools to elucidate how multi-phosphorylation regulates the self-assembly and activity of two IDPs: the cancer-related APC protein and the neurodegenerative diseases-related Tau protein.
  2. Inhibiting structured and disordered domains simultaneously: We developed a strategy for inhibiting the structured and disordered hot spots of an interaction using chimeric peptides that contain both structured and disordered parts, which target both structured and disordered hot spots at the same protein.  The approach is demonstrated for inhibiting the anti-apoptotic iASPP protein.  
  3. Specific targeting of cancer cells by a designed peptide: We developed a peptide that specifically targets cancer cells and kills them by activating cell death pathways. The peptide is derived from the NAF-1 protein and acts by selectively penetrating the plasma membrane of cancer cells and targeting their mitochondria-ER network. 
  4. Inhibiting protein aggregation in disease: Strategies to inhibit aggregation in disease usually focus on highly specific inhibitors for one hotspot but have not made a clinical impact yet. We developed a systematic approach for designing chaperone-like peptides targeting early aggregation stages populated by dynamic precursors, before a mechanistic differentiation takes place. Peptides designed using this strategy inhibited aggregation of disease-related proteins that aggregate in completely different pathways and may serve as general lead compounds against numerous protein aggregation diseases.

References:
[1] Mamidi et al (2019) Org Biomol Chem 17(42):9284-9290
[2] Mayer et al (2019) Nature Comm 10(1):1261
[3] Bressler et al (2023) Int J Mol Sci 24(7):6478
[4] Bressler et al (2025) Org Biomol Chem 23(29):6912-6923
[5] Mayer et al (2022) ACS Chemical Biology 17(7):1811-1823
[6] Sohn et al (2022) Chem Sci 13(23):6929-6941
[7] Garfagnini et al (2024) Chemistry – A European Journal 30(52):e202400080.



SUSTAINABLE 3D CFD MODELLING – A CONTRADICTION IN TIMES OF ENERGY-GUZZLING DATA CENTERS? OR: MODELS ON TOP OF MODELS
Madeleine Witting1; Yongxiang Li1; Markus Schuhmacher1; Candela Romero2; Martin Bultmann3
1Abbvie Deutschland GmbH & Co. KG, Ludwigshafen, Germany; 2ETH Zürich Energie- und Prozesssystemtechnik CLA F 19.3, Zürich, Switzerland; 3University of Heidelberg, Heidelberg, Germany
sips25_73_308_FS

CFD (computational fluid dynamics) modelling has gained a lot of momentum throughout the last decade and also becomes a valuable tool in biopharma. Taking the example of mixing in Single Use System (SUS) Mixers as an example, this paper discusses the huge advantages that CFD modelling brings for gaining deeper insights into mixing in these novel mixers but also shows the downsides of CFD modelling in general and its environmental impact under sustainability aspects and how Super-Designed Modelling can help significantly.

Mixing liquids is a basic operation frequently performed in the biopharmaceutical sector for both small-scale (beakers or flasks) and large-scale, e.g. bioreactors. In bioreactors, upstream as well as downstream processes are key when compounding, pooling, mixing and filling from large tanks.

So far, smooth-walled stainless-steel containers with standardized lapper bottoms have mostly/ widely been used on a larger scale together with common mixing impellers (located usually around the lower third of the container) For these set-ups mixing processes are well established, characterized extensively and generally scaled using P/V (energy input as a power to volume ratio).

For various business and regulatory reasons, efforts have recently been made to switch to Single Use Systems (SUS) for mixing as well/additionally. Here, specially sized three-dimensional plastic bags are hooked into a support cover. To minimize shear stress on biopharmaceuticals, the SUS impellers have entirely different shapes compared to those that were previously common; they sit floating in cup-shaped recesses at the bottom of the bag and are usually also eccentrically displaced. In addition, even when carefully inserted into the support cover and being filled, the bags do not form a smooth wall but have a creased or wrinkled surface.

When submitting new drugs for approval, the authorities require comprehensive knowledge of the product not only regarding the pharmacological, toxicological and clinical aspects, but also regarding the formulation and manufacturing process, which includes mixing.

Accordingly, the characterization of mixing processes in SUS is of great importance.

While experimental mixer validation is usually unproblematic in small-scale, large-scale experimental mixing tests involving extreme parameters (e.g. different speeds, filling volumes, etc.) present almost insurmountable obstacles, because the products are not only extremely expensive in larger quantities but also are usually not available to a sufficient extent in the early phases of development.

Typically, modelling approaches come into play at such a stage [1].

Computational fluid dynamics (CFD) simulations offer a path forward to gain insights into mixing behavior despite these challenges.

However, CFD simulations require a lot of computational power, especially for high-resolution simulations. Several days of computing are rule rather than exception, even on high performance multi core GPU clusters. The energy consumption of a simple 50L mixing, resembling only minutes of real time operation, might require approx. 43kWh. This equals the power consumption of a fridge/freezer combination operated for 3 months or 2 months of operating a laptop 24/7 under normal load.

Superdesigned modelling (SDM) is an approach to tackle the two downsides of CFD modelling at once: Time and energy consumption. The general questions to be answered by CFD simulation of mixing are usually:

  1. What is the required mixer speed for sufficient mixing, while minimizing splashing, foaming, and air incorporation?
  2. What is the required mixing time thereof?
  3. What is the extent of shear stress on a biologic drug substance?

This means that from the vast amount of three-dimensional data, which are generated over tiny high resolution timesteps, only three(!) computed numbers make up/comprise the relevant output. As inputs there are mainly fill level, proportion of liquids to be mixed, their densities and viscosities.

Developing Design of Experiments (DOEs) around simulations by using these inputs as factors for a DOE and conducting the appropriate simulations forms the foundation for SDM.

Although the number of required simulations for a given mixer/impeller combination is kept to a minimum, the performed and analyzed DOE allows for an interpolation of data for any given input combination. As a result, the model can predict output parameters without running additional CFD simulations. Since the model also serves as an analytical equivalence of the simulations, it could be used to derive underlying functional dependencies and uncover even more knowledge around mixing.

References:
[1] Bultmann, J M, SUSTAINABILITY IN BIG PHARMA – CAN SUPERCOMPUTING DO THE TRICK?. [proceedings] SUSTAINABLE INDUSTRIAL PROCESSING SUMMIT AND EXHIBITION, Iraklion, Crete, 2024



THE ALTRUISTIC COMPONENT OF SUSTAINABILITY: FUNDING OF YOUNG SCIENTISTS – A SUCCESS STORY
Martin Bultmann1; Eva Roblegg2; Cornelia Sonntag3
1University of Heidelberg, Heidelberg, Germany; 2Institute of Pharmaceutical Sciences, Pharmaceutical Technology and Biopharmacy, Graz, Austria; 3Galenus Privatstiftung, Wien, Austria
sips25_73_306_FS

Young researchers in academia face a lot of hurdles while establishing their scientific careers. They are caught up in a series of traps where one can’t be overcome by overcoming all the others as well: time, funding, publishing, research, teaching, being present at conferences, expanding their skillset, building and getting into networks etc. All those topics are intertwined; all shall be served at once and all at the fullest extent possible.

Consequentially, this situation has a high potential of becoming a vicious circle unless it is broken at one or more points.

Here, foundations can set in and help in multiple ways to break the circle and overcome this conundrum effectively. One example is the Galenus-Privatstiftung [1], a non-profit scientific foundation that aims to support postdocs, habilitation candidates, assistant and junior professors in the field of pharmaceutical technology and biopharmacy. The foundation awards the Galenus Supports, the Technology Prize, enables visiting professorships as well as international workshops.

References:
[1] Galenus Privatstiftung (website in english) [Internet]. [cited 29.08.2025]. Available from https://www.galenusprivatstiftung.at/english
[2] Roblegg E, Bultmann M: From “publish or perish” to “publish and perish” – young scientists being struck between science and funding. [proceedings] SUSTAINABLE INDUSTRIAL PROCESSING SUMMIT AND EXHIBITION, Cebu, Philippines, 2025
[3] Der hohe Preis des Publizierens [Internet]. [cited 25.08.2025]. Available from https://science.orf.at/stories/3204272/
[4] Open Access - 9.500 Euro pro Studie [Internet]. [cited 25.08.2025]. Available from https://science.orf.at/stories/3203164/
[5] United Nations Department of Economic and Social Affairs: Sustainability Development Goals [Internet]. [cited 22.Apr.2024]. Available from http://sdgs.un.org/goals
[6] Gentile J, Boehlert S: Nurturing Young Scientists, Science, 2010 p.884
[7] University of Graz: Was ist der Research Careers Campus Graz? [Internet]. [cited 16.09.2025]. Available from https://research-careers-campus.uni-graz.at/de/team-organisation/
[8] Pain E: An Emerging Global Picture of Early-Career Scientists [Internet]. [cited 29.08.2025]. Available from https://www.science.org/content/article/emerging-global-picture-early-career-scientists
[9] Wikipedia "Nachhaltigkeit" [Internet]. [cited 17.Apr.2024]. Available from de.wikipedia.org/wiki/Nachhaltigkeit
[10] Wikipedia "Sustainability" [Internet]. [cited 17.Apr.2024]. Available from en.wikipedia.org/wiki/Sustainability
[11] Purvis B., Mao Y., Robinson D.: Three pillars of sustainability: in search of conceptual origins, Sustain Sci, 2019 p.681-695
[12] Kongoli F.: Role of Science and Technology in Sustainable Development. Montreal (Canada): FLOGEN Star Outreach; 2016. p.14.01.2024.
[13] Bultmann, J M: SUSTAINABILITY IN BIG PHARMA – CAN SUPERCOMPUTING DO THE TRICK? [proceedings] SUSTAINABLE INDUSTRIAL PROCESSING SUMMIT AND EXHIBITION, Iraklion, Crete, 2024



TREATMENT OF RADIOACTIVE WASTE OF FISSION REACT0RS
Hans Leuenberger1; Angelo Comunetti2
1University of Florida, Orlando, United States; 2Gempenstrasse 13, CH-4104, Oberwil, Switzerland
sips25_73_297

Radioactive waste of fission reactors is a problem and needs special treatment for keeping it at a safe location, so that radioactive waste can decay without contaminating the environment. Radioactive waste is the product of the nuclear absorption of neutrons (n, g) in a fission nuclear power plant for achieving electricity without using fossil fuels releasing CO2. 1Interestingly, this nuclear reaction (n, g) can be reversed by inducing a photonuclear reaction (g, n) If the corresponding - ray source is available. Interestingly, this g - ray source has to be in resonance with the original (n, g) reaction. Angelo Comunetti could show with his experiments that he could reverse the reaction (n, g) of 197Au->198Auand in addition induce (g, n) reactions of 197Au -> 196Pt. Thus, Angelo Comunetti started to doubt that Neutron Activation Analysis NAA is always working since his subsequent NAA showed that no more Au was present…

Interestingly, Angelo Comunetti also was able to demonstrate that he could induce the photonuclear reaction (g, n) in case of 24Na -> leading to 23Na and to (g, n) of 23Na leading to 22Na, respectively to the volatile 22Ne.

Conclusion: The original reaction (g, n) is reversible and it is feasible to transform the radioactive waste of fission power plants into non-radioactive waste, which does not need to be buried in a safe location.

References:
[1] Angelo Comunetti & Hans Leuenberger, Blockage of the first excited state of 198Hg, Proceedings 2023 SIPS Summit, Panama,
[2] Leuenberger, Hans, Blockage of the first excited state of 198Hg, Proceedings 2023 SIPS Summit, Panama,pptx presentation.
[3] Angelo Comunetti & Hans Leuenberger Treatment of Radioactive Waste of Fission Reactors, pptx Presentation SIPS 2025 Summit, Dusit Thani, Mactan Resort, Cebu, Philippines, Nov. 17- 20, 2025.






COMING SOON!